PropionylproMazine-D6 hydrochloride
Modify Date: 2025-08-26 08:52:45
PropionylproMazine-D6 hydrochloride structure
|
Common Name | PropionylproMazine-D6 hydrochloride | ||
|---|---|---|---|---|
| CAS Number | 1262770-67-1 | Molecular Weight | 382.980 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C20H19D6ClN2OS | Melting Point | N/A | |
| MSDS | USA | Flash Point | N/A | |
Use of PropionylproMazine-D6 hydrochloridePropionylpromazine-d6 hydrochloride is the deuterium labeled Propionylpromazine hydrochloride. Propionylpromazine hydrochloride (Propiopromazine hydrochloride), a dopamine receptor D2 (DRD2) antagonist, can be used in the research of Parkinson disease[1]. |
| Name | PropionylproMazine-D6 hydrochloride |
|---|---|
| Synonym | More Synonyms |
| Description | Propionylpromazine-d6 hydrochloride is the deuterium labeled Propionylpromazine hydrochloride. Propionylpromazine hydrochloride (Propiopromazine hydrochloride), a dopamine receptor D2 (DRD2) antagonist, can be used in the research of Parkinson disease[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
| References |
[2]. Tyers, Mike, et al. Method for treating a brain cancer with ifenprodil. US8058243. |
| Molecular Formula | C20H19D6ClN2OS |
|---|---|
| Molecular Weight | 382.980 |
| Exact Mass | 382.175262 |
| RIDADR | NONH for all modes of transport |
|---|
| 1-[10-(3-{Bis[(2H3)methyl]amino}propyl)-10H-phenothiazin-2-yl]-1-propanone hydrochloride (1:1) |
| 1-Propanone, 1-[10-[3-(dimethyl-d3-amino)propyl]-10H-phenothiazin-2-yl]-, hydrochloride (1:1) |